Summit clinical team visits Life Science Robotics for ROBERT® training

This week the Summit Medical and Scientific clinical team travelled to Aalborg, Denmark, where we were welcomed by Life Science Robotics and got hands on with the ROBERT®.

After comprehensive product training we visited customers for a live demonstration, to meet their inspiring patients, and to see the impact ROBERT® has on patient recovery.

A huge thank you to the entire team at Life Science Robotics for their hospitality, it was great to meet you all and we are looking forward to a fantastic partnership together!

About the ROBERT®

The ROBERT® is an innovative robotic rehabilitation device that focuses on delivering efficient therapy for clinicians and providing active and early mobilisation for acute patients. The unique 7 degrees of freedom allows therapists to perform and record an initial movement, and then the device repeats this to deliver the desired frequency and intensity. This can include Activities of Daily Living and Proprioceptive Neuromuscular Facilitation.

The ROBERT® uniquely trains both the upper and lower limb with the same device, and can be used either in-bed or seated. Optional Functional Electrical Stimulation (FES)

ROBERT® is developed by Life Science Robotics and distributed in the UK by Summit Medical and Scientific. Read more about the ROBERT® here.

About Summit Medical and Scientific

Summit Medical and Scientific are passionate about the power of rehabilitation technology.

We represent clinical technology leaders Hocoma, Motek and Life Science Robotics to provide the total solution for rehabilitation in the UK. Our partners have developed innovative therapy devices using robotics, sensors and virtual reality for early and acute rehabilitation, gait and balance therapy, arm and hand therapy, body weight support and more. View all of our clinical solutions here.

Get in touch with Summit Medical and Scientific today to find out more about incorporating state-of-the-art rehabilitation technology into your practice.

You can also follow us on Facebook, Twitter and LinkedIn, and subscribe to our newsletter for the latest updates.